SEATTLE, April 15 /PRNewswire/ -- Milliman, Inc., a premier global consulting and actuarial firm, today announced it
Many summaries of the Interim Final Rules have been provided that address the general provisions contained in the rules. This webinar will provide a more in depth look at some of the key considerations that have come from actually performing compliance testing. It will also include discussion of compliance with the non-quantitative treatment limitations, which is an area that cannot be ignored.
Lastly, Steve will present a strong case for using the Act as a catalyst for employers and health plans to invest in behavioral healthcare.
For the past 15 years, Milliman actuary Steve Melek has immersed himself in the myriad aspects of behavioral healthcare. During the initial phases of the legislative process for MHPAEA, he was involved in performing the cost impact analysis of the parity legislation, and gave testimony before Congress summarizing the results. More recently, he has been involved in numerous discussions about MHPAEA with many stakeholders, and has begun assisting health plans and employers understand what changes must be made to plan designs to comply with the law. Aside from his involvement with mental health parity, Steve has also recently helped health plans develop, implement, and measure the performance of integrated medical / behavioral healthcare programs, including the use of creative predictive modeling approaches.
If you are interested in attending this free event, please send your request to firstname.lastname@example.org for complete log-in instructions.
Milliman is among the world's largest independent actuarial and consulting firms. Founded in Seattle in 1947 as Milliman & Robertson, the company currently has 52 offices in key locations worldwide. Milliman employs more than 2,400 people. The firm has consulting practices in healthcare, employee benefits, property & casualty insurance, life insurance, and financial services. Milliman serves the full spectrum of business, financial, government, union, education, and nonprofit organizations. For further information, visit www.milliman.com.
SOURCE Milliman, Inc.
Subscribe to our Free Newsletters!
Nootropics are drugs or substances which improve cognition that are being increasingly used ...